Johan Raud, MD, PhD, is co-founder and Chief Scientific Officer at RSPR Pharma AB. He has more than 25 years of academic, industrial and financial experience from different positions within the healthcare area. He brings experience from AstraZeneca, where he headed research teams, managed drug discovery projects and worked with business intelligence. Prior to his current position, he was also Partner at Karolinska Investment Fund, a venture capital fund with a health care focus. Johan gained his MD, PhD and Associate Professorship at Karolinska Institutet and has published some 75 scientific papers, mainly in the area of inflammation pharmacology.
pharmacology.